Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.
Saved in:
| Title: | Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study. |
|---|---|
| Authors: | Stein, Cy A.1, Levin, Richard2, Given, Robert3, Higano, Celestia S.4, Nemeth, Paul5 pnemeth@churchillpharma.com, Bosch, Bill5, Chapas-Reed, Jillian5, Dreicer, Robert6 |
| Source: | Urologic Oncology. Feb2018, Vol. 36 Issue 2, p81.e9-81.e16. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
